"Daptomycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA.
Descriptor ID |
D017576
|
MeSH Number(s) |
D04.345.566.270 D10.477.500 D12.644.365.500 D12.644.641.270
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Daptomycin".
Below are MeSH descriptors whose meaning is more specific than "Daptomycin".
This graph shows the total number of publications written about "Daptomycin" by people in this website by year, and whether "Daptomycin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2007 | 2 | 0 | 2 |
2009 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Daptomycin" by people in Profiles.
-
Sahu KK, Mahagaokar K, Patel B, Winokur D, Suzuki S, Daly JS, Ramanathan M, Cerny J. Strongyloides stercoralis hyperinfection syndrome in mantle cell lymphoma in post-transplant setting. Ann Hematol. 2021 Apr; 100(4):1089-1091.
-
Peleg AY, Miyakis S, Ward DV, Earl AM, Rubio A, Cameron DR, Pillai S, Moellering RC, Eliopoulos GM. Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus. PLoS One. 2012; 7(1):e28316.
-
Rehm S, Campion M, Katz DE, Russo R, Boucher HW. Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy. J Antimicrob Chemother. 2009 May; 63(5):1034-42.
-
Abraham G, Finkelberg D, Spooner LM. Daptomycin-induced acute renal and hepatic toxicity without rhabdomyolysis. Ann Pharmacother. 2008 May; 42(5):719-21.
-
Katz DE, Martone WJ. Community-phenotype-methicillin-resistant Staphylococcus aureus infections: a retrospective chart review of outcomes after treatment with daptomycin. Clin Ther. 2007 Nov; 29(11):2440-7.
-
Krige JE, Lindfield K, Friedrich L, Otradovec C, Martone WJ, Katz DE, Tally F. Effectiveness and duration of daptomycin therapy in resolving clinical symptoms in the treatment of complicated skin and skin structure infections. Curr Med Res Opin. 2007 Sep; 23(9):2147-56.
-
Skiest DJ. Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin. J Clin Microbiol. 2006 Feb; 44(2):655-6.
-
Rotondi KS, Gierasch LM. A well-defined amphipathic conformation for the calcium-free cyclic lipopeptide antibiotic, daptomycin, in aqueous solution. Biopolymers. 2005; 80(2-3):374-85.